VTYX Stock VTYX is expected to report earnings to rise+13.76% to -68 cents per share on May 09

A.I.dvisor
at Tickeron.com
05/08/24
Loading...
VTYX - Ventyx Biosciences
Ventyx Biosciences Earnings Graph
Q1'24
Est.
$-0.68
Q4'23
Beat
by $0.08
Q3'23
Missed
by $0.02
Q2'23
Missed
by $0.21
Q1'23
Missed
by $0.08
The last earnings report on December 31 showed earnings per share of -79 cents, beating the estimate of -87 cents. P/B Ratio (1.332) is normal, around the industry mean (10.346). P/E Ratio (0.000) is within average values for comparable stocks, (113.451). VTYX's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.447). VTYX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (0.000) is also within normal values, averaging (231.135). With 342.92K shares outstanding, the current market capitalization sits at 325.00M.
View a ticker or compare two or three
VTYXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12790 El Camino Real
Phone
+1 760 593-4832
Employees
80
Web
https://www.ventyxbio.com